Kazuyoshi Suenari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazuyoshi Suenari has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Yukiko Nakano
Department of Cardiovascular Medicine Hiroshima University Graduate School of Biomedical and Health Sciences Hiroshima Japan
7 shared publications Kazuaki Chayama
Hiroshima University Graduate School of Biomedical Sciences
6 shared publicationsNoboru Oda
From the Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical & Health Sciences, Hiroshima, Japan (A.S., C.M., H.I., H.K., H.M., K.S., M.T., Noboru Oda, Nozomu Oda, S. Tomomori, S.K., T.T., Y. O., Y.K., Y.N., Y.W.); Laboratory for Digestive Diseases, Center for Integrative Medical Sciences, RIKEN, Hiroshima, Japan (D.M., H.O., K.C., Y.N.); Division of Frontier Medical Science, Department of Gastroenterology and Metabolism, Programs for Biomedical Research...
6 shared publicationsNobuo Shiode
Department of Cardiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
6 shared publicationsHiroshi Ogi
Hiroshima University Graduate School of Biomedical Sciences
5 shared publicationsHidekazu Hirao
Department of Cardiology Hiroshima Prefectural Hospital Hiroshima Japan
4 shared publications
Latest Publications
- 26 December 2025
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (6) , 1-9
Optimizing electrode spacing of a pentaspline pulsed field ablation catheter for high-precision 3D mapping
Background Pulsed field ablation (PFA) is emerging as a nonthermal and myocardium-selective therapy for atrial fibrillation. Integration of the FARAWAVE™ catheter with the EnSite™ X three-dimensional electroanatomical mapping (3D-EAM) system remains in development, and the optimal display style, interelectrode spacing, and field scaling (FS) settings have not been established. Objective To determine the optimal visualization configuration of the FARAWAVE™ catheter for achieving high geometric accuracy in 3D mapping. Methods We retrospectively analyzed 25 patients with atrial fibrillation who underwent PFA using the FARAWAVE™ pentaspline catheter visualized on the EnSite™ X system. Four configurations were tested: Medusa style (2.5 mm) and Garland styles (1–17–1 mm, 1–12–1 mm, and 1–11–1 mm). CT-derived left atrial anatomies were compared with electroanatomical reconstructions using ten concordance metrics (six distances and four angles). Accuracy was assessed with mean absolute error (MAE), Scale Score, Angle Score, and Shape Similarity. Results Distance-based MAE differed significantly among configurations (p < 0.05). The Garland 1–11–1 mm + FS setting achieved the lowest MAE (4.3–12.4 mm), while Garland 1–17–1 mm had the highest (8.5–28.4 mm). Scale Score also varied significantly (p < 0.001), whereas Angle Score and Shape Similarity were comparable across configurations. Conclusion The Garland 1–11–1 mm configuration with Field Scaling provided the most accurate geometric concordance with CT anatomy. Optimized catheter display and FS correction can improve mapping fidelity and procedural safety in pulsed field ablation.
- 26 December 2025
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (6) , 1-9
Optimizing electrode spacing of a pentaspline pulsed field ablation catheter for high-precision 3D mapping
Background Pulsed field ablation (PFA) is emerging as a nonthermal and myocardium-selective therapy for atrial fibrillation. Integration of the FARAWAVE™ catheter with the EnSite™ X three-dimensional electroanatomical mapping (3D-EAM) system remains in development, and the optimal display style, interelectrode spacing, and field scaling (FS) settings have not been established. Objective To determine the optimal visualization configuration of the FARAWAVE™ catheter for achieving high geometric accuracy in 3D mapping. Methods We retrospectively analyzed 25 patients with atrial fibrillation who underwent PFA using the FARAWAVE™ pentaspline catheter visualized on the EnSite™ X system. Four configurations were tested: Medusa style (2.5 mm) and Garland styles (1–17–1 mm, 1–12–1 mm, and 1–11–1 mm). CT-derived left atrial anatomies were compared with electroanatomical reconstructions using ten concordance metrics (six distances and four angles). Accuracy was assessed with mean absolute error (MAE), Scale Score, Angle Score, and Shape Similarity. Results Distance-based MAE differed significantly among configurations (p < 0.05). The Garland 1–11–1 mm + FS setting achieved the lowest MAE (4.3–12.4 mm), while Garland 1–17–1 mm had the highest (8.5–28.4 mm). Scale Score also varied significantly (p < 0.001), whereas Angle Score and Shape Similarity were comparable across configurations. Conclusion The Garland 1–11–1 mm configuration with Field Scaling provided the most accurate geometric concordance with CT anatomy. Optimized catheter display and FS correction can improve mapping fidelity and procedural safety in pulsed field ablation.
- 4 June 2022
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 26 (3) , 229-231
Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imaging
- 4 June 2022
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 26 (3) , 229-231
Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imaging
- 1 April 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (4) , 530-536
New Minimally Invasive and Tailor-Made Strategy for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation
- 1 April 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (4) , 530-536
New Minimally Invasive and Tailor-Made Strategy for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation
- 16 March 2021
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 64 (2) , 281-290
Comparison between cryoballoon and hot balloon ablation in patients with paroxysmal atrial fibrillation
Purpose Pulmonary vein (PV) isolation using balloon ablation was developed as a technique for patients with paroxysmal atrial fibrillation (PAF). While most studies examined cryoballoon ablation (CBA), there have also been many reports on hot balloon ablation (HBA). We aimed to evaluate the clinical characteristics and outcomes between HBA and CBA. Methods In a total of 103 consecutive patients with PAF who underwent catheter ablation, 60 propensity score–matched (30 CBA and 30 HBA) patients were enrolled. The procedural differences and clinical outcomes between the two groups were analyzed. Results The requirement for additional touch-up ablation was more frequent in the left superior pulmonary vein (LSP) in the HBA group than in the CBA group. Pre-procedural computed tomography (CT) images showed that a thicker left pulmonary vein ridge and larger cross-sectional area of the LSPV were significantly associated with residual PV potentials after HBA. However, post-procedural CT images showed that PV stenosis (> 25%) was higher in the HBA group (33%) than in the CBA group (0%). PV stenosis after HBA was observed most frequently in the right superior PV (50%). The atrial fibrillation/atrial tachycardia–free survival rate during follow-up (365 ± 102 days) was similar between the two groups (CBA vs. HBA, 83% vs. 90%). Conclusions Although both balloon modalities can relieve atrial arrhythmia after the procedure, careful attention is required during HBA procedures, especially for the right superior PV, to avoid PV stenosis.
- 16 March 2021
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 64 (2) , 281-290
Comparison between cryoballoon and hot balloon ablation in patients with paroxysmal atrial fibrillation
Purpose Pulmonary vein (PV) isolation using balloon ablation was developed as a technique for patients with paroxysmal atrial fibrillation (PAF). While most studies examined cryoballoon ablation (CBA), there have also been many reports on hot balloon ablation (HBA). We aimed to evaluate the clinical characteristics and outcomes between HBA and CBA. Methods In a total of 103 consecutive patients with PAF who underwent catheter ablation, 60 propensity score–matched (30 CBA and 30 HBA) patients were enrolled. The procedural differences and clinical outcomes between the two groups were analyzed. Results The requirement for additional touch-up ablation was more frequent in the left superior pulmonary vein (LSP) in the HBA group than in the CBA group. Pre-procedural computed tomography (CT) images showed that a thicker left pulmonary vein ridge and larger cross-sectional area of the LSPV were significantly associated with residual PV potentials after HBA. However, post-procedural CT images showed that PV stenosis (> 25%) was higher in the HBA group (33%) than in the CBA group (0%). PV stenosis after HBA was observed most frequently in the right superior PV (50%). The atrial fibrillation/atrial tachycardia–free survival rate during follow-up (365 ± 102 days) was similar between the two groups (CBA vs. HBA, 83% vs. 90%). Conclusions Although both balloon modalities can relieve atrial arrhythmia after the procedure, careful attention is required during HBA procedures, especially for the right superior PV, to avoid PV stenosis.
- Open Access
- 29 June 2020
- Published by Wiley in Journal of Arrhythmia
- Vol. 36 (4) , 735-736
Editorial to •Trends, burden, and impact of arrhythmia on cardiac amyloid patients: A 16‐year nationwide study from 1999 to 2014•
- 29 June 2020
- Published by Wiley in Journal of Arrhythmia
- Vol. 36 (4) , 735-736
Open AccessEditorial to •Trends, burden, and impact of arrhythmia on cardiac amyloid patients: A 16‐year nationwide study from 1999 to 2014•
- Open Access
- 13 March 2020
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-5
Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
The subcutaneous implantable cardioverter defibrillator (S-ICD) is an alternative to the transvenous implantable cardioverter defibrillator for the prevention of sudden cardiac death. Here, we report a rare case of refractoriness to an S-ICD after frequent therapies for ventricular fibrillation (VF) storms. A 24-year-old man underwent a bout of syncope with vomiting and incontinence at home. He was brought to the emergency room and was witnessed to spontaneously go into VF successfully converted by external defibrillation. Previously, he was diagnosed with a type I Brugada electrocardiogram pattern by a pilsicainide administration test in another hospital. Although he had a family history of sudden cardiac death in 3 relatives, including his brother, he was followed closely without any therapies because he had never had an episode of syncope. He was implanted with an S-ICD without any trouble. Seven months later, frequent S-ICD shocks for VF storms occurred. His VF was controlled by using intravenous amiodarone, which was converted to an oral preparation. However, his VF recurred after another 2 months. The analysis of his S-ICD data revealed that 4 consecutive shock deliveries could not terminate his VF and the final shock delivered could fortunately terminate it because of a high defibrillation threshold test (DFT) due to an increasing shock impedance (64 to 90 Ω). First, we performed an epicardial Brugada syndrome ablation and subsequently replaced and repositioned the S-ICD lead from a left to a right parasternal site. After the re-implantation of the S-ICD, the DFT test improved to within normal range. According to the pathological analysis, infiltration of inflammatory cells and extensive fibrosis were confirmed in the subcutaneous tissue around the shock lead and S-ICD body. Frequent S-ICD shocks for VF storms might cause various pathological changes around the device and lead to a high DFT.
- 13 March 2020
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-5
Open AccessRefractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
The subcutaneous implantable cardioverter defibrillator (S-ICD) is an alternative to the transvenous implantable cardioverter defibrillator for the prevention of sudden cardiac death. Here, we report a rare case of refractoriness to an S-ICD after frequent therapies for ventricular fibrillation (VF) storms. A 24-year-old man underwent a bout of syncope with vomiting and incontinence at home. He was brought to the emergency room and was witnessed to spontaneously go into VF successfully converted by external defibrillation. Previously, he was diagnosed with a type I Brugada electrocardiogram pattern by a pilsicainide administration test in another hospital. Although he had a family history of sudden cardiac death in 3 relatives, including his brother, he was followed closely without any therapies because he had never had an episode of syncope. He was implanted with an S-ICD without any trouble. Seven months later, frequent S-ICD shocks for VF storms occurred. His VF was controlled by using intravenous amiodarone, which was converted to an oral preparation. However, his VF recurred after another 2 months. The analysis of his S-ICD data revealed that 4 consecutive shock deliveries could not terminate his VF and the final shock delivered could fortunately terminate it because of a high defibrillation threshold test (DFT) due to an increasing shock impedance (64 to 90 Ω). First, we performed an epicardial Brugada syndrome ablation and subsequently replaced and repositioned the S-ICD lead from a left to a right parasternal site. After the re-implantation of the S-ICD, the DFT test improved to within normal range. According to the pathological analysis, infiltration of inflammatory cells and extensive fibrosis were confirmed in the subcutaneous tissue around the shock lead and S-ICD body. Frequent S-ICD shocks for VF storms might cause various pathological changes around the device and lead to a high DFT.
- Open Access
- 1 September 2017
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 10 (9)
Cauliflower-Like Appearance of Calcified Nodules Observed by Coronary Angioscopy
- 1 September 2017
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 10 (9)
Open AccessCauliflower-Like Appearance of Calcified Nodules Observed by Coronary Angioscopy
- Open Access
- 1 June 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (7) , 1162-1166
Idiopathic left ventricular tachycardia following atrioventricular conduction block by rapid atrial tachycardia
Key Clinical Message: The present case demonstrated a rare situation alternating between a repetitive atrial tachycardia ( AT ) and ventricular tachycardia ( VT ). A unique induction mechanism was noted in which the VT was induced after Wenckebach AV node conduction block following the repetitive rapid AT .
- 1 June 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (7) , 1162-1166
Open AccessIdiopathic left ventricular tachycardia following atrioventricular conduction block by rapid atrial tachycardia
Key Clinical Message: The present case demonstrated a rare situation alternating between a repetitive atrial tachycardia ( AT ) and ventricular tachycardia ( VT ). A unique induction mechanism was noted in which the VT was induced after Wenckebach AV node conduction block following the repetitive rapid AT .
- 21 April 2016
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 27 (8) , 918-922
Electrical Remodeling of the Atrioventricular Node Caused by Persistent Atrial Fibrillation in Humans
Background An animal experiment showed that long‐term atrial pacing or persistent atrial fibrillation (AF) caused electrical remodeling of the atrioventricular (AV) node. We aimed to test the hypothesis that persistent AF decreases the AV conductivity in human hearts. Methods and Results We retrospectively compared the cardiac electrophysiological properties between patients with paroxysmal AF who underwent catheter ablation (PXAF, N = 254) and those with persistent or longstanding persistent AF (PSAF, N = 213). The PSAF patients were more likely than PXAF patients to have longer atrial‐His (AH) (96.3 ± 25.7 vs. 91.3 ± 20.4 milliseconds; P = 0.02) and His‐ventricle (HV) (43.1 ± 9.4 vs. 41.2 ± 8.6 milliseconds; P = 0.02) intervals. The AV nodal effective refractory period (ERP) (299.1 ± 74.6 vs. 276.2 ± 58.9 milliseconds; P < 0.001) and Wenckebach cycle length (420.9 ± 80.3 vs. 386 ± 58.6 milliseconds; P < 0.001) were also more prolonged in the PSAF patients. We found a dual AV nodal physiology with a similar frequency in both groups. The AH interval, fast pathway ERP, and Wenckebach cycle length in the PSAF patients were more likely than in the PXAF patients to be prolonged among the patients without dual pathways, while those intergroup differences were never seen among the patients with dual pathways. In subgroup analyses including only PSAF patients, there was no difference in the AV conductivity between the patients with persistent AF and those with longstanding persistent AF. Conclusions Persistent AF may cause a mild decrease in the AV nodal function in human hearts. Electrical remodeling may be uncommon if dual AV nodal pathways are present, and its extent may not depend on the duration of persistent AF.
- 21 April 2016
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 27 (8) , 918-922
Electrical Remodeling of the Atrioventricular Node Caused by Persistent Atrial Fibrillation in Humans
Background An animal experiment showed that long‐term atrial pacing or persistent atrial fibrillation (AF) caused electrical remodeling of the atrioventricular (AV) node. We aimed to test the hypothesis that persistent AF decreases the AV conductivity in human hearts. Methods and Results We retrospectively compared the cardiac electrophysiological properties between patients with paroxysmal AF who underwent catheter ablation (PXAF, N = 254) and those with persistent or longstanding persistent AF (PSAF, N = 213). The PSAF patients were more likely than PXAF patients to have longer atrial‐His (AH) (96.3 ± 25.7 vs. 91.3 ± 20.4 milliseconds; P = 0.02) and His‐ventricle (HV) (43.1 ± 9.4 vs. 41.2 ± 8.6 milliseconds; P = 0.02) intervals. The AV nodal effective refractory period (ERP) (299.1 ± 74.6 vs. 276.2 ± 58.9 milliseconds; P < 0.001) and Wenckebach cycle length (420.9 ± 80.3 vs. 386 ± 58.6 milliseconds; P < 0.001) were also more prolonged in the PSAF patients. We found a dual AV nodal physiology with a similar frequency in both groups. The AH interval, fast pathway ERP, and Wenckebach cycle length in the PSAF patients were more likely than in the PXAF patients to be prolonged among the patients without dual pathways, while those intergroup differences were never seen among the patients with dual pathways. In subgroup analyses including only PSAF patients, there was no difference in the AV conductivity between the patients with persistent AF and those with longstanding persistent AF. Conclusions Persistent AF may cause a mild decrease in the AV nodal function in human hearts. Electrical remodeling may be uncommon if dual AV nodal pathways are present, and its extent may not depend on the duration of persistent AF.
- 1 January 2016
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 9 (1) , e003436
Common Variant Near HEY2 Has a Protective Effect on Ventricular Fibrillation Occurrence in Brugada Syndrome by Regulating the Repolarization Current
Background—: Risk stratification of Brugada syndrome (BrS) remains controversial and the majority of patients with BrS have no genetic explanation. We investigated relationships between genotypes of 3 single-nucleotide polymorphisms reported in a recent genome-wide association study and BrS phenotypes. Methods and Results—: SCN10A (rs10428132), SCN5A (rs11708996), and downstream from HEY2 (rs9388451) single-nucleotide polymorphisms were genotyped and compared between 95 Japanese patients with BrS and 1978 controls. Relationships between the single-nucleotide polymorphisms and clinical characteristics, 12-lead ECG findings, signal-averaged ECG findings, and electrophysiological parameters were also examined in patients with BrS. Both rs10428132 and rs9388451 were significantly associated with BrS ( P =2.7×10 −14 ; odds ratio, 3.0; P =9.2×10 −4 ; odds ratio, 1.7, respectively). Interestingly, the HEY2 risk allele C was less frequent in BrS patients with ventricular fibrillation than in those without (59% versus 74%; P =4.1×10 −2 ; odds ratio, 0.5). A significant linear correlation was found between HEY2 genotypes and QTc interval (CC: 422±27 ms; CT: 408±21 ms; and TT: 381±27 ms; P = 4.0×10 −4 ). The HEY2 mRNA expression level in the right ventricular specimens from patients with BrS (n=20) was significantly lower in patients with CC genotype than the other genotypes ( P =0.04). Additionally, during 63±28 months follow-up periods after implantable cardioverter defibrillator implantation (n=90), Kaplan–Meier event-free survival curves revealed that the cumulative rate of ventricular fibrillation events was significantly lower in cases with HEY2 CC genotype ( P =0.04). Conclusions—: Our findings suggest that HEY2 CC genotype may be a favorable prognostic marker for BrS, protectively acting to prevent ventricular fibrillation presumably by regulating the repolarization current.
- 1 January 2016
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 9 (1) , e003436
Common Variant Near HEY2 Has a Protective Effect on Ventricular Fibrillation Occurrence in Brugada Syndrome by Regulating the Repolarization Current
Background—: Risk stratification of Brugada syndrome (BrS) remains controversial and the majority of patients with BrS have no genetic explanation. We investigated relationships between genotypes of 3 single-nucleotide polymorphisms reported in a recent genome-wide association study and BrS phenotypes. Methods and Results—: SCN10A (rs10428132), SCN5A (rs11708996), and downstream from HEY2 (rs9388451) single-nucleotide polymorphisms were genotyped and compared between 95 Japanese patients with BrS and 1978 controls. Relationships between the single-nucleotide polymorphisms and clinical characteristics, 12-lead ECG findings, signal-averaged ECG findings, and electrophysiological parameters were also examined in patients with BrS. Both rs10428132 and rs9388451 were significantly associated with BrS ( P =2.7×10 −14 ; odds ratio, 3.0; P =9.2×10 −4 ; odds ratio, 1.7, respectively). Interestingly, the HEY2 risk allele C was less frequent in BrS patients with ventricular fibrillation than in those without (59% versus 74%; P =4.1×10 −2 ; odds ratio, 0.5). A significant linear correlation was found between HEY2 genotypes and QTc interval (CC: 422±27 ms; CT: 408±21 ms; and TT: 381±27 ms; P = 4.0×10 −4 ). The HEY2 mRNA expression level in the right ventricular specimens from patients with BrS (n=20) was significantly lower in patients with CC genotype than the other genotypes ( P =0.04). Additionally, during 63±28 months follow-up periods after implantable cardioverter defibrillator implantation (n=90), Kaplan–Meier event-free survival curves revealed that the cumulative rate of ventricular fibrillation events was significantly lower in cases with HEY2 CC genotype ( P =0.04). Conclusions—: Our findings suggest that HEY2 CC genotype may be a favorable prognostic marker for BrS, protectively acting to prevent ventricular fibrillation presumably by regulating the repolarization current.